The Company shall use the proceeds, first, for the acquisition of a 10% interest in Alternative Solutions LLC dba Oasis Medical Cannabis, and expenses related thereto, including related commitment fees up to 10% of the gross proceeds; and thereafter any remaining proceeds may be used for any of the following purpose in the Company’s sole discretion:  (i) repaying all or part of the amounts due to FirstFire under the Prior Note, (ii) to pay the cost for patent applications domestically or abroad, (iii) to pursue listing of the Company’s securities on a Canadian stock exchange, and (iv) for general working capital purposes.